Synergy Innovation Co., Ltd. (KOSDAQ:048870)
South Korea · Delayed Price · Currency is KRW 1,476.00
+14.00 (0.96%)
At close: Oct 21, 2026
Synergy Innovation Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 116,562 | 113,050 | 90,605 | 83,215 | 86,539 | 30,705 |
Revenue Growth | 16.45% | 24.77% | 8.88% | -3.84% | 181.84% | -55.46% |
Gross Profit Gross Profit Growth | 51,789 | 50,042 | 37,864 | 31,320 | 39,340 | 6,030 |
Operating Income Operating Income Growth | 18,872 | 19,155 | 16,110 | 14,985 | 22,927 | 1,211 |
Net Income Net Income Growth | 10,027 | 3,011 | 10,371 | 2,305 | 16,128 | 5,719 |
Earnings Per Share EPS Growth | 114.42 | 34.80 | 125.00 | 27.34 | 199.00 | 74.85 |
EPS Growth | - | -72.16% | 357.12% | -86.26% | 165.88% | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biotechnology Business Biotechnology Business Growth | 22,272 | 21,276 | 20,825 | 18,166 | 13,522 | 18,160 |
Adjustment and removal Adjustment and removal Growth | - | -980.95 | - | -1,788 | -4,442 | - |
Other Other Growth | 1,689 | 2,400 | 1,200 | - | - | - |
Health Function Food Business Health Function Food Business Growth | 13,335 | 14,069 | 14,827 | 18,663 | 16,797 | 12,546 |
Medical Business Medical Business Growth | 80,647 | 76,286 | 53,753 | 48,174 | 60,662 | - |
Total Total Growth | 116,562 | 113,050 | 90,605 | 83,215 | 86,539 | 30,705 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 90,741 | 82,854 | 106,645 | 104,566 | 44,570 | 32,893 |
Total Debt Total Debt Growth | 29,930 | 35,896 | 41,077 | 26,310 | 37,106 | 29,627 |
Net Cash (Debt) Net Cash Growth | 60,812 | 46,958 | 65,569 | 78,256 | 7,463 | 3,266 |
Net Cash Growth | 8.12% | -28.38% | -16.21% | 948.54% | 128.52% | 9.04% |
Net Cash Per Share Net Cash Per Share Growth | 693.93 | 542.59 | 792.77 | 941.82 | 92.17 | 42.73 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,968 | 14,778 | 26,475 | 35,367 | 12,871 | 20,423 |
Capital Expenditures CapEx Growth | -6,221 | -5,370 | -1,822 | -1,568 | -1,001 | -2,042 |
Free Cash Flow Free Cash Flow Growth | 11,747 | 9,407 | 24,652 | 33,798 | 11,870 | 18,381 |
Free Cash Flow Growth | -26.32% | -61.84% | -27.06% | 184.74% | -35.42% | 285.76% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 44.43% | 44.27% | 41.79% | 37.64% | 45.46% | 19.64% |
Operating Margin | 16.19% | 16.94% | 17.78% | 18.01% | 26.49% | 3.94% |
Pretax Margin | 19.36% | 14.28% | 24.06% | 32.10% | 16.96% | -5.08% |
Profit Margin | 8.60% | 2.66% | 11.45% | 2.77% | 18.64% | 18.63% |
FCF Margin | 10.08% | 8.32% | 27.21% | 40.62% | 13.72% | 59.86% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.90 | 68.61 | 20.70 | 97.97 | 14.31 | 59.94 |
P/FCF Ratio | 11.07 | 21.96 | 8.71 | 6.68 | 19.44 | 18.65 |
PS Ratio | 1.12 | 1.83 | 2.37 | 2.71 | 2.67 | 11.16 |